By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the mRNA Cancer Vaccine Summit 2023, an extraordinary gathering that brings together pioneers in the field of mRNA cancer vaccines. Set in the vibrant city of Boston, this summit marks a pivotal moment in the community's journey towards groundbreaking advancements in cancer treatment.Dedicated to showcasing the latest technology breakthroughs, translational insights, and crucial clinical updates, the mRNA Cancer Vaccine Summit 2023 is the first and only platform of its kind. Here, global leaders converge to exchange knowledge and expertise, working tirelessly to harness the potential of neoantigens and develop tailor-made mRNA cancer vaccines that hold immense promise.This summit provides a unique opportunity for professionals in the mRNA cancer vaccine, oncology, and immune-oncology fields to stay at the forefront of the latest innovations in cancer therapy. By joining this event, you will gain invaluable insights into the cutting-edge advancements driving personalized neoantigen therapies in clinical settings. The agenda includes a dedicated day focused on neoantigen discovery and identification, with the aim of optimizing the process of developing personalized cancer vaccines and accelerating your pipelines.The mRNA Cancer Vaccine Summit 2023 fosters collaboration and knowledge exchange among experts, fostering an environment of innovation and progress. As the field of mRNA cancer vaccines continues to evolve rapidly, this event serves as a catalyst for accelerating the translation of research into tangible solutions that can transform the lives of cancer patients worldwide.Join us at the mRNA Cancer Vaccine Summit 2023 and be part of the collective effort to bring novel and effective mRNA cancer vaccines to patients faster. Together, we can push the boundaries of cancer treatment and make a lasting impact on the fight against this devastating disease.
Explore mRNA cancer vaccine technology advances, translational insights and critical clinical updates.
Explore the latest advances and novel technologies towards improved immunogenicity and reduced toxicity of your mRNA cancer vaccine candidates with insights from NeoMatrix & HDT Bio.
With individualized neoantigen therapies showing critical promise in the clinic, neoantigen leaders unite to exhibit a whole-day dedicated to neoantigen discovery and identification, towards optimized discovery and development of personalized cancer vaccines to differentiate and fast track your pipelines
Uncover the latest clinical data on mRNA cancer vaccines candidates and review future innovations in the oncology treatment landscape with insights from Genentech & Moderna.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
The event had a good atmosphere and engaging sessions, making it a worthwhile experience.
Personalis?is a leader in advanced cancer genomics for enabling the next generation of precision cancer therapies and diagnostics.
Make faster and better informed drug development decisions In partnership with the world’s leading drug development experts to help you keep up with the pace of preclinical and clinical research developments.
As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions.
4basebio is enabling next generation cell and gene therapies and vaccines with its technologies and solutions. We are able to design, manufacture and supply application-specific synthetic DNA or mRNA as well as targeted non-viral vectors for the deli
4basebio is enabling next generation cell and gene therapies and vaccines with its technologies and solutions. We are able to design, manufacture and supply application-specific synthetic DNA or mRNA as well as targeted non-viral vectors for the delivery of nucleic acid payloads.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.